ATM | Offering amount: $8,943,000 | Amount sold to date: $0 | Float: 4,836,476
424B5
ATM | Offering amount: $41,636,612 | Amount sold to date: $8,363,388
424B5
ATM | Offering amount: $10,000,000
424B3
8,226,834 shares of Common Stock
Registrations
TYPE
HEADLINE
FILED AT
POS AM
SPA | Shares: 350,000,000
S-1/A
Chardan - SPA - Shares may be sold to Chardan from time to time under the Purchase Agreement at prices tied to the prevailing market, provided that the average price of all sales equals or exceeds the Nasdaq “Minimum Price” of $0.6277 per share unless stockholders approve issuances below that level. The company cannot issue shares to Chardan that would exceed 19.99% of the shares outstanding immediately before the agreement (the “Exchange Cap”) unless either the minimum-price condition is satisfied or shareholder approval is obtained. Up to 350,000,000 shares are available for purchase, with the exact number sold in each draw determined by separate purchase notices and the constraints of the Exchange Cap.
S-1
Chardan - SPA - Shares may be sold to Chardan from time to time under the Purchase Agreement at prices tied to the prevailing market, provided that the average price of all sales equals or exceeds the Nasdaq “Minimum Price” of $0.6277 per share unless stockholders approve issuances below that level. The company cannot issue shares to Chardan that would exceed 19.99% of the shares outstanding immediately before the agreement (the “Exchange Cap”) unless either the minimum-price condition is satisfied or shareholder approval is obtained. Up to 350,000,000 shares are available for purchase, with the exact number sold in each draw determined by separate purchase notices and the constraints of the Exchange Cap.
S-3
SHARE RESALE REGISTRATION
POS AM
Form POS AM - Post-Effective amendments for registration statement
S-1
OFFERING (Best Efforts Offering) - Roth Capital Partners
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
DEFM14A
Form DEFM14A - Definitive proxy statement relating to merger or acquisition
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
PREM14A
Form PREM14A - Preliminary proxy statements relating to merger or acquisition
DEF 14A
Form DEF 14A - Other definitive proxy statements
Ownerships
TYPE
HEADLINE
FILED AT
SCHEDULE 13G/A
LYTTON LAURENCE W (Filed by)
SCHEDULE 13G/A
LYTTON LAURENCE W (Filed by)
3
DNA Holdings Venture Inc. (Reporting)
SCHEDULE 13D
DNA Holdings Venture Inc. (Filed by)
SCHEDULE 13G/A
LYTTON LAURENCE W (Filed by)
SCHEDULE 13G/A
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
